Skip to content

VerTouch Device: A Prospective Randomized Controlled Trial

Does the VerTouch Device Improve Insertion Site Identification for Lumbar Neuraxial Procedures When Compared to Palpation or Ultrasound Guided Site Selection? A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04630171
Enrollment
86
Registered
2020-11-16
Start date
2021-01-01
Completion date
2023-11-29
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pregnancy

Keywords

Pregnancy, Neuraxial Anesthesia, Therapeutic Lumbar Puncture, Ultrasound, Labor epidural, Spinal Procedure

Brief summary

This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.

Detailed description

Thousands of neuraxial procedures are completed daily with over 12,000 done at Prentice Women's hospital last year. These procedures are not without difficulty and complication. The gold standard of palpation and blind advancement of the needle toward the spine can result in multiple insertions of the needle into the skin and redirections of the trajectory of that needle after insertion to avoid the bones of the spine protecting the spinal column. These insertions and redirections are not only time consuming while the patient is in an uncommon position, but they also cause dis-comfort and possibly lasting pain days after the procedure. In addition to the patient dynamics, when anatomical or positioning issues result in difficult neuraxial procedures the common teaching is to attempt US guided access. Unfortunately, not many proceduralist are trained in this modality and the additional materials needed to perform the procedure with US take time to gather and further prolong the procedure. Additionally, though the cost of US technology is getting more reasonable, it is still rather expensive and a barrier to utilization by many facilities around the country and the world. Often, after many attempts, the proceduralist accepts failure of the procedure and refers the patient to the interventional radiology (IR) or pain medicine specialist for completion of the procedure using radiation to visualize the spine. Note, this is not an option for pregnant women who are not eligible for radiation due to fetal concerns. The VerTouch device offers a non-invasive, untethered, and non-radiation producing device that allows for the visualization of the underlying structures of the spine to determine ideal needle placement for neuraxial procedures. The output on the screen can also be visualized by other providers or senior proceduralist for assistance with best course of action for the procedure. The device does not cause discomfort to the patient and does not require any additional materials to be functional. Study participants will be recruited from Prentice Women's Hospital (Northwestern Medicine). Pregnant patients tend to be healthy and without comorbidities, and the anesthesiologists who perform the neuraxial procedure tend to have significant experience. Non-pregnant patients tend to require neuraxial access for diagnostic or therapeutic purposes (i.e. not for the relief of labor pains), and therefore have comorbidities. Labor & Delivery: Participants will be randomized to one of the three arms (palpation, US, or VerTouch). This study has the potential to show that the VerTouch is more effective than palpation and as effective as US at defining the location for neuraxial procedure initiation and eventual success.

Interventions

DEVICEGroup #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure

Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia

DEVICEGroup #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure

Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia

OTHERGroup #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure

Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia

Sponsors

Intuitap
CollaboratorUNKNOWN
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Participant will be blinded to what procedure will be used to identify lumbar landmarks. All devices will be in the room with the operator of the devices.

Intervention model description

Prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients 18 years old and above * Undergoing a neuraxial procedure

Exclusion criteria

* Non English speaking * Plastic allergy * Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Number of Redirections of the NeedleEnd of procedurePrimary endpoint is the number of redirections of the needle

Secondary

MeasureTime frameDescription
Number of Reinsertions of the Needle24 hours.Secondary endpoint is the number of reinsertions of the needle.
Total Procedure Time24 hoursTotal neuraxial procedure time in minutes

Countries

United States

Participant flow

Participants by arm

ArmCount
Group 1: VerTouch for Labor Epidural or Spinal Anesthesia Procedure
VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia. Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure: Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia
32
Group 2: Ultrasound (US) for Labor Epidural or Spinal Anesthesia Procedure
Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia. Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure: Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia
26
Group 3: Control Group, Palpation for Labor Epidural or Spinal Anesthesia Procedure
Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure in women requesting labor analgesia. Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure for women requesting labor analgesia
28
Total86

Baseline characteristics

CharacteristicGroup 1: VerTouch for Labor Epidural or Spinal Anesthesia ProcedureTotalGroup 3: Control Group, Palpation for Labor Epidural or Spinal Anesthesia ProcedureGroup 2: Ultrasound (US) for Labor Epidural or Spinal Anesthesia Procedure
Age, Continuous34.4 Years34.3 Years34.6 Years34.3 Years
BMI = Weight (kg) / Height (m)²29.32 kg/m^230.58 kg/m^231.12 kg/m^231.6 kg/m^2
Height (in)65.09 Inches64.8 Inches64.51 Inches64.69 Inches
Race/Ethnicity, Customized
Hispanic
2 Participants12 Participants4 Participants6 Participants
Race/Ethnicity, Customized
Non-Hispanic
30 Participants72 Participants23 Participants19 Participants
Race/Ethnicity, Customized
Not reported
0 Participants2 Participants1 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants6 Participants3 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants6 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants9 Participants4 Participants4 Participants
Race (NIH/OMB)
White
25 Participants65 Participants20 Participants20 Participants
Region of Enrollment
United States
32 Participants86 Participants28 Participants26 Participants
Sex: Female, Male
Female
32 Participants86 Participants28 Participants26 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants0 Participants
Weight (Kilograms)80.01 Kilograms84.04 Kilograms83.5 Kilograms85.2 Kilograms

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 260 / 28
other
Total, other adverse events
0 / 320 / 260 / 28
serious
Total, serious adverse events
0 / 320 / 260 / 28

Outcome results

Primary

Number of Redirections of the Needle

Primary endpoint is the number of redirections of the needle

Time frame: End of procedure

ArmMeasureValue (MEAN)Dispersion
Group 1: VerTouch for Labor Epidural or Spinal Anesthesia ProcedureNumber of Redirections of the Needle.72 Number of redirections of needleStandard Deviation 0.9
Group 2: Ultrasound (US) for Labor Epidural or Spinal Anesthesia ProcedureNumber of Redirections of the Needle2.81 Number of redirections of needleStandard Deviation 3.7
Group 3: Control Group, Palpation for Labor Epidural or Spinal Anesthesia ProcedureNumber of Redirections of the Needle2.35 Number of redirections of needleStandard Deviation 3.9
Secondary

Number of Reinsertions of the Needle

Secondary endpoint is the number of reinsertions of the needle.

Time frame: 24 hours.

ArmMeasureValue (MEAN)Dispersion
Group 1: VerTouch for Labor Epidural or Spinal Anesthesia ProcedureNumber of Reinsertions of the Needle.11 Number of needle insertionsStandard Deviation 0.3
Group 2: Ultrasound (US) for Labor Epidural or Spinal Anesthesia ProcedureNumber of Reinsertions of the Needle.96 Number of needle insertionsStandard Deviation 1.5
Group 3: Control Group, Palpation for Labor Epidural or Spinal Anesthesia ProcedureNumber of Reinsertions of the Needle.5 Number of needle insertionsStandard Deviation 1
Secondary

Total Procedure Time

Total neuraxial procedure time in minutes

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Group 1: VerTouch for Labor Epidural or Spinal Anesthesia ProcedureTotal Procedure Time8.66 MinutesStandard Deviation 2.6
Group 2: Ultrasound (US) for Labor Epidural or Spinal Anesthesia ProcedureTotal Procedure Time9.81 MinutesStandard Deviation 4.1
Group 3: Control Group, Palpation for Labor Epidural or Spinal Anesthesia ProcedureTotal Procedure Time7.88 MinutesStandard Deviation 3.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026